Canary Speech Earns HITRUST e1 Certification
Canary Speech (Provo, UT) announces it has obtained HITRUST e1 Certification, reinforcing its commitment to cybersecurity related to its voice biomarker technology.
Tech News
Provo, Utah – July 9, 2025
Canary Speech, a pioneer in AI-powered voice biomarker technology, announced today that its platform—hosted on Microsoft Azure—has achieved HITRUST e1 Certification, verifying that essential cybersecurity controls are in place to protect sensitive health data. The certification validates foundational security practices in a cloud environment increasingly used to support clinical decision-making.
“In today’s environment, it’s imperative that organizations like ours keep pace with current and emerging threats,” said Henry O’Connell, CEO at Canary Speech. “We are pleased to demonstrate to customers our commitment to cybersecurity and data protection through HITRUST e1 Certification.”
Robert Booker, Chief Strategy Officer at HITRUST, noted that the e1 assessment is well-suited for companies building their security posture in highly regulated industries:
“The HITRUST e1 Validated Assessment is a good tool for cyber-aware organizations like Canary Speech that want to build assurances and progressively demonstrate due diligence around information security and privacy. We applaud Canary Speech for their commitment to cybersecurity and successful completion of their HITRUST e1 Certification.”
In parallel with its security advancements, Canary Speech continues to scale on the strength of its intellectual property and technical capabilities:
- The company has secured 14 granted patents, with 6 more pending, focused on non-invasive voice-based health diagnostics.
- Its platform is capable of analyzing more than 15 million vocal data points per minute, allowing for robust, real-time speech analysis across clinical and contact center environments.
This technical infrastructure powers Canary Ambient™, the company’s flagship API-based tool for passive voice analysis. It delivers immediate insights into mental and cognitive health during patient-clinician conversations, enabling earlier detection of conditions like anxiety, depression, and neurodegenerative disorders.
“Earning the HITRUST e1 Certification reinforces our strategic commitment to building a trusted, scalable technology foundation,” said Jeremy McFadden, Chief Information Officer at Canary Speech. “As we expand our voice biomarker solutions across healthcare and life sciences, maintaining robust cybersecurity and compliance practices isn’t just operationally necessary—it’s essential to enabling long-term innovation, partnerships, and market leadership.”
Headquartered in Provo, UT, Canary Speech is an AI-powered developer of a speech recognition technology designed to detect neurological and cognitive diseases. Canary Speech's technology monitors speech irregularities for early signs of various neurological conditions such as Parkinson's, dementia and Alzheimer's. It analyzes the neurological conditions of the patients, enabling the identification of early warning and early diagnosis of diseases affecting cognitive function.
A year ago the company raised a $13 million Series A funding round led by Cortes Capital (Oklahoma City), with participation from new investors Sorenson Communications (Taylorsville, UT), SMK (Tokyo, Japan), and Hackensack Meridian Health (Edison, NJ).
For more information, visit Canary Speech here.